UK clears J&J's oral pill for psoriasis

Britain's medicines regulator has approved Johnson & Johnson's oral psoriasis pill Icotyde for patients aged 12 and above. The decision rests on four clinical studies in which people taking the tablet showed better results after 16 weeks than those given a placebo. The approval gives patients a pill-based alternative for managing the chronic skin condition.